Fnu Sadarat

Fnu Sadarat practices at Olean General Hospital in Olean, New York, part of Kaleida Health.

Fnu Sadarat's NPI, 1962925248, was assigned on July 19, 2017. Fnu Sadarat holds New York license 306084.

Fnu Sadarat's primary practice is Olean General Hospital, at 515 Main Street, Olean, NY 14760 in Cattaraugus County. The practice phone is (716) 373-2600.

Fnu Sadarat's primary practice is Olean General Hospital in Olean, New York, part of Kaleida Health. Fnu Sadarat is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is Apogee Physicians. Dmand AI also links Fnu Sadarat to 1 more medical group, named with a free account. Fnu Sadarat's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Fnu Sadarat practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Fnu Sadarat's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Fnu Sadarat is licensed in New York.

CMS data shows 618 Medicare services from Fnu Sadarat across 5 procedure codes in 2024, for 239 Medicare patients. Medicare paid $44,139 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 239 Medicare patients who saw Fnu Sadarat in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Fnu Sadarat's median patient age at 69, with 54% women.

In 2024, Fnu Sadarat wrote 549 Medicare Part D claims for 180 patients. 89% of them were for generic drugs. CMS names the drug for 307 of them, across 14 drugs with 11 or more claims each, at $16,942 in total drug cost. In 2023, CMS named 197 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Fnu Sadarat for performance year 2024, reported as part of a group. Fnu Sadarat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Fnu Sadarat, published from 2023 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Randomized Controlled Trials as Topic. Fnu Sadarat has published most often in BMC Cardiovasc Disord. Fnu Sadarat's most frequent co-authors are Zubair Rahaman, MD, Deepak Kumar, MD and Puja K. Mehta, MD.

CMS Open Payments shows 38 general payments to Fnu Sadarat from 12 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $169.